Wird geladen...

CREB Signals as PBMC-based Biomarkers of Cognitive Dysfunction: A Novel Perspective of the Brain-Immune Axis

To date, there is no reliable biomarker for the assessment or determination of cognitive dysfunction in Alzheimer’s disease and related dementia. Such a biomarker would not only aid in diagnostics, but could also serve as a measure of therapeutic efficacy. It is widely acknowledged that the hallmark...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain Behav Immun
Hauptverfasser: Bartolotti, Nancy, Lazarov, Orly
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488430/
https://ncbi.nlm.nih.gov/pubmed/30641141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbi.2019.01.004
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!